Head and neck diseases contain tumors, infections, inflammation, and other lesions. These diseases often involve tissues in the mouth, throat, larynx, nasal cavity, paranasal sinuses, ears, and neck.

A local researcher and seasoned executives founded a company that will bring new medical technology to market.

Non-small cell lung cancer (NSCLC) remains a predominant cause of cancer-related mortality worldwide. In recent years, immune checkpoint inhibitors (ICIs) have emerged as a transformative therapeutic ...

Clatterbridge was the first cancer research centre in the UK to give an injection of the Transgene experimental immunotherapy ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

A breast cancer vaccine could be closer to reality, according to Cleveland Clinic, as its researchers have announced some encouraging results. Researchers and doctors weigh in.

As Merck prepares for its blockbuster immunotherapy Keytruda to face generic competition, it’s investing in a new cancer drug from LaNova.

UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer ...

The company is paying China-based biotech LaNova Medicines $588 million for the kind of dual-pronged antibody drug that ...

In a small subset of those patients, the combination resulted in a strong response with tumor shrinkage and no disease ...

Aggressive non-Hodgkin lymphoma is typically treated with intravenous chemo-immunotherapy. "This is a cocktail of various ...

Researchers have created a groundbreaking antibody that combines targeting, delivery, and immune activation to treat cancer, ...